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ABSTRACT: Apolipoprotein A-I (ApoA-I), a major component of HDL, binds haptoglobin, a plasma protein
transporting to liver or macrophages free Hb for preventing hydroxyl radical production. This work aimed
to assess whether haptoglobin protects ApoA-I against this radical. Human ApoA-I structure, as analyzed
by electrophoresis and MS, was found severely altered by hydroxyl radicals in vitro. Lower alteration of
ApoA-I was found when HDL was oxidized in the presence of haptoglobin. ApoA-I oxidation was limited
also when the complex of haptoglobin with both high-density lipoprotein and Hb, immobilized on resin
beads, was exposed to hydroxyl radicals. ApoA-I function to stimulate cholesterol esterification was assayed
in vitro by using ApoA-I-containing liposomes. Decreased stimulation was observed when liposomes
oxidized without haptoglobin were used. Conversely, after oxidative stress in the presence of haptoglobin
(0.5 íM monomer), the liposome activity did not change. Plasma of carrageenan-treated mice was analyzed
by ELISA for the levels of haptoglobin and ApoA-I, and used to isolate HDL for MS analysis.
Hydroxyproline-containing fragments of ApoA-I were found associated with low levels of haptoglobin
(18 íM monomer), whereas they were not detected when the haptoglobin level increased (34-70 íM
monomer). Therefore haptoglobin, when circulating at enhanced levels with free Hb during the acute
phase of inflammation, might protect ApoA-I structure and function against hydroxyl radicals.
The process of removal and transport of cholesterol from
peripheral cells to liver, known as reverse cholesterol
transport, is mediated by high-density lipoprotein (HDL1)
(1), and is of fundamental importance for prevention or
reversal of atherosclerotic cardiovascular diseases (2). Free
or lipid-poor forms of the apolipoprotein (Apo) A-I serve
as acceptor targets for cholesterol and phospholipids from
arterial wall macrophages. These particles, called nascent
HDL, use ApoA-I to stimulate the enzyme lecithin-
cholesterol acyl-transferase (LCAT, EC 2.3.1.45) for con-
verting cell-derived cholesterol into ester forms, which are
then placed into the lipoprotein core and change the particle
shape and mass. Then HDL transports cholesterol and
cholesteryl esters to liver, where these are selectively uptaken
for production of bile acids, while ApoA-I is bound by
specific cell receptors (3-5). Thus ApoA-I plays crucial roles
in key steps of reverse cholesterol transport. In addition,
ApoA-I binds also steroidogenic cells, which are thus
provided with cholesterol for hormone synthesis (6). The
function of this apolipoprotein may be severely altered by
structure modifications, as those resulting from genetic
factors (7) or oxidative damage (8-12). There is a growing
belief that atherosclerotic cardiovascular diseases develop
from vascular injury associated with inflammation (13, 14).
In particular, the immune response and the resulting oxidative
stress severely contribute to monocyte infiltration into the
arterial wall, where they differentiate into macrophages and,
after cholesterol accumulation, foam cells (14). Therefore
importance and efficiency of reverse cholesterol transport
should be considered into the frame of inflammatory or
oxidative processes. ApoA-I should be protected against
oxidative stress, and several factors might be involved to
prevent the attack of oxidants, thus saving the HDL function
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in cholesterol transport. Antioxidant factors are mostly
enzymes or free radical scavengers including nonenzyme
proteins (15). Haptoglobin (Hpt), a polymorphic protein with
enhanced plasma levels during the acute phase of inflam-
mation (16), plays its antioxidant role by binding free Hb
and forming a complex which is sequestered by liver or
macrophages (17, 18). Free or Hpt-bound Hb can trigger the
Fenton reaction (19) from H2O2 originated by the vascular
endothelium (20-22) or macrophages (15). This reaction
oxidizes ferrous to ferric ion in Hb, producing the highly
aggressive hydroxyl radical (19). The radical production can
be reiterated as much as ascorbate molecules are available
to recycle ferric ions back to the reduced state (23). Hpt also
binds ApoA-I (24, 25) by domain(s) different from those
capturing Hb (26). The ApoA-I domain interacting with Hpt
is also (partially) required for stimulating LCAT (27, 28).
Therefore the binding of Hpt to ApoA-I has been suggested
to be an important regulatory factor for the LCAT activity
(27). The amount of Hpt-bound ApoA-I depends on the ratio
of Hpt with ApoA-I, and this ratio was found higher and
negatively correlated with the LCAT activity in patients with
rheumatoid arthritis (29), which is a pathologic condition
associated with inflammation (30, 31). Hpt might shield
ApoA-I against harmful oxidants. In fact, Hpt has a molecular
mass far greater than that of ApoA-I (16) and might scavenge
oxidants by its reducing amino acid residues (15). On the
other hand Hpt can form a complex with both Hb and
ApoA-I (25, 26), thus keeping ApoA-I very close to the
source of hydroxyl radicals. In this case, Hpt might address
the radical attack just to immobilized ApoA-I.
The purpose of our work was to study structure alteration
of ApoA-I exposed to hydroxyl radicals, and ascertain
whether Hpt, in conditions of oxidative stress similar to those
present during inflammation, prevents or limits such an
alteration. Correlation of Hpt level with ApoA-I hydroxy-
lation was studied in mice treated with carrageenan. Informa-
tion on the LCAT stimulatory function of ApoA-I, under-
going oxidative stress with or without Hpt, is also reported.
EXPERIMENTAL PROCEDURES
Materials. Chemicals of the highest purity, BSA, HSA,
cholesterol, cholesteryl linoleate, human Hpt (mixed phe-
notypes), rabbit anti-human Hpt IgG, GAR-HRP IgG, ABTS,
DS (Dextralip 50), carrageenan, and molecular mass markers,
were purchased from Sigma-Aldrich (St. Louis, MO). The
peptide P2a (SPLGEEMRDRARAHVDALRTHLA) was
synthesized by INBIOS (Pozzuoli, Italy). Human ApoA-I
and rabbit anti-human ApoA-I polyclonal IgG were from
Calbiochem (La Jolla, CA). (1R,2R-3H)Cholesterol (45 Ci/
mmol) was obtained from Perkin-Elmer (Boston, MA).
Modified porcine trypsin was from Promega (Madison, WI)-
. Hi-Trap NHS-activated sepharose (Amersham Biosciences,
Buckinghamshire, U.K.) and PVDF transfer membrane
(Millipore, Bedford, MA) were used.
HDL Oxidation and LCAT Assay. HDL were isolated from
pooled plasma of healthy donors as previously published
(32). The oxidation system was constituted by a reaction
mixture with 100 íM H2O2 and 100 íM ascorbate in TBS
(TBS: 130 mM NaCl, 20 mM Tris-HCl, pH 7.4), supple-
mented with Hb as below described. The radical production
was monitored by measuring the absorbance at 734 nm of
reaction mixtures, containing 6 íM Hb and 450 íM ABTS,
kept at 37 °C (33). Radicals were no more produced after 1
h of incubation as ABTS, when added to the reaction mixture
at this time, was not converted into colored products. HDL
oxidation was carried out by incubating the reaction mixture
with 0.15 mg/mL lipoprotein and 6 íM Hb (15 min, 37 °C).
This oxidation was performed, when required, in the presence
of 12 íM HSA or Hpt. ApoA-I-containing proteoliposomes,
prepared as below described, were oxidized with different
concentrations of Hb (0.5, 1.5, 2.5, or 3.2 íM) in the presence
of 0.5 íM Hpt, or with 0.5 íM Hb in the presence of
different concentrations of Hpt (0.5, 1, 3, or 10 íM).
Competition of ApoA-I with P2a for binding Hpt was carried
out by a proteoliposome oxidation mixture containing 0.5
íM Hb and 0.5 íM Hpt, supplemented with different P2a
concentrations (3, 9, 30, or 90 íM). The molarity of Hpt
was calculated as concentration of monomers R-â (27). The
LCAT assay was performed, with proteoliposomes untreated,
or oxidized in different conditions, as previously published
(27). The enzyme activity was determined as nanomoles of
cholesterol incorporated per hour per milliliter of plasma,
and expressed in units (U).
Electrophoresis and Immunoblotting. Electrophoresis was
carried out in denaturing and reducing conditions on a 1.5
mm thick slab gel of 15% polyacrylamide, as previously
reported (34). Molecular mass markers (BSA, 66 kDa; egg
albumin, 45 kDa; glyceraldehyde-3-phosphate dehydroge-
nase, 36 kDa; carbonic anhydrase, 29 kDa; trypsinogen, 24
kDa; trypsin inhibitor, 20 kDa; R-lactalbumin, 14 kDa) were
used as standards of the protein electrophoretic mobility. Gel
fixing and staining were omitted when the gel was processed
for immunoblotting analysis.
Western blotting onto PVDF membrane and staining by
antibodies were carried out essentially as previously de-
scribed (35). In particular, proteins were transferred to PVDF
membrane, which was treated with anti-ApoA-I IgG, and
then stained by GAR-HRP IgG using 4 mM 4-chloro-1-
naphthol for detecting immunocomplexes.
Gels were processed for MS analysis as follows. Small
slices of Coomassie-stained gels (1.5 mm thick, 10 mm wide,
1.5-2 mm long) were manually excised, and destained
overnight with 40% ethanol in 25 mM ammonium bicarbon-
ate. The gel pieces were washed twice with 25 mM
ammonium bicarbonate and desiccated three times with
acetonitrile. Each piece was then reswollen in 16 íL of 25
mM ammonium bicarbonate containing 0.8 íg trypsin. After
overnight digestion at 37 °C, peptides were extracted by
sonication in 25 mM ammonium bicarbonate and analyzed
by MS.
Affinity Chromatography. Hi-Trap NHS-activated resin
was used to prepare stationary phases for affinity chroma-
tography. Hb was linked to the resin, according to the
manufacturer’s instructions. Hb (1 mg) was coupled with
0.5 mL of resin beads. After coupling, the Hb-coupled resin
was divided into two equal aliquots, which were packed in
separated small columns, and equilibrated with 10 volumes
of 50 mM sodium phosphate at pH 7.4 (P buffer). One
column was loaded with 100 íL of 58 íM Hpt at 0.2 mL/
min, and then washed by P buffer at 1 mL/min (until the
effluent absorbance at 280 nm was <0.01 OD/mL) to remove
unbound protein. The column which was not treated with
Hpt served as control. Both columns were loaded, at 0.2 mL/
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min, with 100 íL of native HDL containing 28 íM Apo
A-I in P buffer. Unbound HDL was washed out from the
Hpt-Hb column by TBS. A solution (90 íL) of 100 íM
H2O2 and 100 íM ascorbate in TBS was absorbed by each
column, and the flow through was discarded. After 15 min
at 37 °C, the columns were eluted with 0.1 M glycine-HCl
at pH 2.8. The eluted proteins were pooled, concentrated by
centrifugation under vacuum, and processed for electro-
phoresis.
Treatment of Mice and Analysis of Plasma and Isolated
HDL. Male Swiss mice (CD-1; Charles River, Italy) were
injected with 1% carrageenan in isotonic saline solution,
according to a published procedure (36). The effect of
inflammation was studied in animals sacrificed by carbon
dioxide 6, 24, 48, 72, 96, and 144 h after injection. At each
time length a group of animals (N ) 3) was sacrificed, and
their plasma was prepared. One group of untreated mice
served as control. An aliquot of plasma (50 íL) from each
mouse was sampled for titration of ApoA-I and Hpt. Another
aliquot (350 íL) was pooled with equal aliquots from mice
belonging to same group, and used for MS analysis. The
level of ApoA-I and Hpt was determined by ELISA using
mouse antigens, isolated by published procedures (26, 37)
and exhibiting over 98% purity by electrophoresis and
densitometry analysis, as standards for calibration. The
plasma pool was in part (50 íL) directly analyzed for the
albumin level by MS, and in part (900 íL) treated with 0.1%
DS and 50 mM MnCl2 in TBS to precipitate lipoproteins
other than HDL, which were removed by centrifugation.
Supernatant HDL precipitated in 0.65% DS and 200 mM
MnCl2 in TBS, and were pelletted by centrifugation. The
pellet was dissolved in 400 íL of TBS and then processed
for MS analysis. The experiments on mice were conducted
adhering to the requirements of the University of Naples
Federico II for the care and use of laboratory animals.
NanoLC-Nanospray MS/MS Analysis. Peptides from hu-
man proteins fractionated by electrophoresis were prepared
as above described. Peptides from mouse apolipoproteins
were obtained by overnight incubation of isolated HDL with
47 íg/mL trypsin at 37 °C. Each peptide sample (1 íL) was
loaded onto a ZORBAX 300 (75 ím  150 mm, 3.5 ím
particles) SB-C18 RP column (Agilent Italia, Milan, Italy)
and eluted with a 50 min gradient of acetonitrile from 5%
to 95% in 0.1% formic acid, at a 0.3 íL/min flow rate by a
HP 1100 nanoHPLC system (Agilent Italia, Milan, Italy)
coupled to a XCT-Plus nanospray-ion trap mass spectrometer
(Agilent Italia, Milan, Italy). MS parameters were the
following: 100-2200 m/z scan range, 8100 m/z s-1 scan
speed, 5 L/min dry gas flow, 300 °C dry temperature, 1.8
kV capillary, 40 V skimmer, 125000 ion charge control (ICC)
target, 300 ms maximum accumulation time. Positively
charged peptide ions were automatically isolated and frag-
mented, and spectra were deconvoluted by the Data Analysis
software (Bruker Daltonics, Bremen, Germany). For nanoLC-
nanospray MS/MS experiments the NCBInr database and
Mascot search algorithm (http://www.matrixscience.com/
search_form_select.html) were chosen. Peptide tolerance (
1.8 Da, MS/MS tolerance ( 0.8 Da, significance threshold
p < 0.05 were used. Considered modifications were me-
thionine oxidation, proline hydroxylation, and sodium adduct
to aspartate, glutamate, and C-terminus.
Statistical Analysis. Each sample in all the experiments,
except those from mice, was processed at least in triplicate,
and the datum was expressed as mean value ( SEM.
Samples in experiments with mice were processed in
duplicate to obtain averages and deviations; interassay
coefficients of variation, for signal intensity at each time
length of treatment, from three separate experiments were
calculated. The program “Graph Pad Prism 3” (Graph Pad
Software, San Diego, CA) was used to perform t-test
analysis.
RESULTS
ApoA-I Oxidation by Hydroxyl Radicals and Hpt Protec-
tiVe Effect. A system for producing hydroxyl radicals by
Fenton chemistry was set up, using the conversion of Hb
ferrous into ferric ions to feed the reaction H2O2 f HOs +
HO¥. Recycling of oxidized iron back to its reduced form, a
mandatory step to extend this process when H2O2 is in
stoichiometric excess, was obtained by supplementing the
reaction mixture with ascorbate. Radical production was
monitored by measuring the amount of colored ABTS¥+
cations originating from the reaction of HO¥ with ABTS.
As shown in Figure 1, the adduct level increased in less than
15 min from the reaction start, but the formed color was not
stable, as fading was observed in extended incubation. This
system of radical production was used to oxidize HDL. The
lipoprotein, when added to the reaction mixture, effectively
competed with ABTS for hydroxyl radicals, as formation of
colored cations resulted remarkably lowered (Figure 1).
These data show that HDL were oxidized by H2O2 concen-
tration similar to that produced in pathological conditions
(15).
After oxidative treatment, the HDL was analyzed by
SDS-PAGE. The pattern of Coomassie-stained proteins
from oxidized HDL, as compared with that from native HDL,
exhibited additional or more intense bands (Figure 2; lane 4
versus lane 2). In particular, the band of oxidized ApoA-I
migrated broader than that of native ApoA-I, with apparent
molecular mass slightly lower than 24 kDa, and several
additional bands were detected all over the protein fraction-
FIGURE 1: Kinetics of hydroxyl radical production. Hydroxyl
radicals were produced by incubating 6 íM Hb with 100 or 50
íM H2O2 in the presence of 100 íM ascorbate at 31 °C. The
reaction mixture contained ABTS, as radical target. Formation and
fading of the colored ABTS¥+ cation with the radical was monitored
by measuring the absorbance of the mixture at 734 nm. Mixtures
supplemented with HDL were analyzed. Open circles: 450 íM
ABTS + 100 íM H2O2. Open triangles: 450 íM ABTS + 50 íM
H2O2. Filled circles: 450 íM ABTS + 100 íM H2O2 + 1 mg/mL
HDL. Filled triangles: 450 íM ABTS + 50 íM H2O2 + 1 mg/mL
HDL.
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ation range. When Hpt was added to the oxidation system,
the HDL pattern was found changed. Actually, in this case,
the heaviest oxidation products were not found and new
bands, not present in the patterns of “untreated” or “treated
without Hpt” HDL, were observed (Figure 2; lane 5 versus
lane 2 or 4 respectively). The proteins separated by electro-
phoresis were also analyzed by immunoblotting. After protein
transfer onto PVDF membrane, rabbit anti-ApoA-I and HRP-
GAR IgG was used to stain ApoA-I and ApoA-I-like
antigens. Native ApoA-I was found migrated as two bands,
accompanied with a band having apparent molecular mass
of 73 kDa (Figure 2; lane 7). This slow migrating band of
ApoA-I-like antigens might be a protein constituted by
ApoA-I cross-linked with other apolipoprotein(s). Samples
of oxidized HDL mostly contained such a band, more intense
than from native HDL, and a slower band (over 80 kDa) of
comparable intensity, accompanied with a number of ad-
ditional antigens migrated in the range of apparent molecular
mass from 66 to 29 kDa (Figure 2; lanes 6). It cannot be
excluded from this experiment that minor oxidative modi-
fications, not influencing the electrophoretic mobility, are
present also in Apo A-I of treated samples. When Hpt was
present during oxidative stress, the antigens detected in the
sample of oxidized HDL seemed just the same observed in
the pattern of untreated HDL (Figure 2; lane 8 versus 7). A
control experiment was carried out by incubating HDL with
HSA in the oxidation mixture. The electrophoretic pattern
of ApoA-I antigens, as detected by immunoblotting, was
similar to that observed from samples of native HDL
incubated without HSA (Figure 2; lane 6 versus lane 9). It
is worth noting that all the analyzed samples contained the
same amounts of HDL, but anti-ApoA-I IgGs reacted with
some ApoA-I-like antigens much better than with ApoA-I.
The data indicate that oxidation alters the electrophoretic
mobility of several HDL proteins, and suggest that antigens
containing ApoA-I epitopes originate from attack of hydroxyl
radicals to ApoA-I structure. The finding that Hpt limits the
production of several oxidation products from HDL, par-
ticularly those with lower electrophoretic mobility, and
prevents the conversion of ApoA-I into antigens with higher
molecular mass suggests that bound Hpt protects ApoA-I
against hydroxyl radicals.
Complex of Hpt with Both Hb and ApoA-I: Hpt-Mediated
Defense of ApoA-I against Radicals from Hb. A large part
of Hpt circulates in the form of a complex with Hb (38).
The Hpt property to bind ApoA-I has above been mentioned.
Since Hpt is a polymorphic protein, present as dimer or
oligomer forms, it is conceivable that it might be simulta-
neously associated with both Hb and ApoA-I. In this case,
it might join the important hydroxyl source Hb with the
hydroxyl target ApoA-I. We therefore wondered whether Hb-
bound Hpt would still be able to protect HDL ApoA-I from
Hb-triggered oxidative damage. Hb was coupled to resin
beads, which were then used to pack two small columns.
One of these columns was loaded with Hpt excess to form
stable Hb-Hpt complexes. After extensive washing for
removing free Hpt, the resin was loaded with HDL, contain-
ing ApoA-I in an amount lower than that of Hb-bound Hpt.
After this treatment, the resin was extensively washed to
remove free HDL. Then, a solution containing ascorbate and
H2O2 was added for stimulating resin-linked Hb to produce
radicals. After incubation, HDL was eluted and analyzed by
SDS-PAGE and immunoblotting. The other column, also
packed with resin-linked Hb, was used as control, as it was
not treated with Hpt, but directly loaded with HDL. This
column was not washed, to avoid HDL release in the effluent,
and incubation with ascorbate and H2O2 was carried out. The
results indicate that ApoA-I, when exposed to radicals, was
partly converted into minor forms with altered electrophoretic
mobility only in the absence of Hpt (Figure 3). This
experiment indicates that Hb-bound Hpt maintains the
property to capture ApoA-I, and suggests that ApoA-I is
protected from oxidative attack even though kept by Hpt
close to the source of hydroxyl radicals.
MS Analysis of the ApoA-I Oxidation Forms. In order to
characterize the degradation pattern of oxidized ApoA-I, we
performed MS analysis of proteins from gels reported in
Figure 2. The tracks of untreated HDL, oxidized HDL, and
FIGURE 2: Electrophoretic analysis of HDL treated by oxidative
stress. Aliquots of HDL solution containing 6 íM ApoA-I were
used. The proteins were fractionated by SDS-PAGE and stained
by Coomassie R250, or blotted onto PVDF membrane for immu-
nostaining with rabbit anti-Apo A-I IgG and HRP-GAR. Samples
of 40 íL were loaded on the gel. Lane 1: Molecular mass standards,
Coomassie-staining. Lane 2: Mixture of native HDL with 6 íM
Hb, Coomassie-staining. Lane 3: HDL incubated with H2O2,
Coomassie-staining. Lane 4: HDL oxidized by Hb/H2O2/ascorbate
(6/100/100 íM respectively), Coomassie-staining. Lane 5: HDL
oxidized by Hb/H2O2/ascorbate in the presence of 12 íM Hpt,
Coomassie-staining. Lane 6: HDL oxidized by Hb/H2O2/ascorbate,
immunoblotting. Lane 7: native HDL, immunoblotting. Lane 8:
HDL oxidized by Hb/H2O2/ascorbate in the presence of 12 íM
Hpt, immunoblotting. Lane 9: HDL oxidized by Hb/H2O2/ascorbate
in the presence of 12 íM HSA, immunoblotting.
FIGURE 3: Electrophoretic analysis of HDL oxidized by bead-
coupled Hb. Columns of sepharose (0.25 mL) were coupled with
Hb. One column was loaded with 0.5 mL of solution containing
1.3 íg/mL HDL (28 íM Apo A-I) and 58 íM Hpt, washed by
TBS, and then loaded with Hb/H2O2/ascorbate. The other column
was loaded with the same HDL amount, and directly loaded with
the oxidation mixture. The retained material was eluted by 0.1 M
glycine-HCl at pH 2.8, and analyzed by SDS-PAGE and
immunoblotting. Lane 1: antigens from the treatment with Hpt.
Lane 2: antigens from the treatment without Hpt. Coomassie
staining of purified ApoA-I and molecular mass markers, fraction-
ated by SDS-PAGE, are shown in lanes 3 and 4 respectively.
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HDL oxidized in the presence of Hpt (Figure 2; lanes 2, 4,
and 5, respectively) were cut each into 19 slices (Figure 4).
Each slice was destained and, then, digested by trypsin for
MS fingerprinting. As a first approach, we characterized the
peptide pool from each gel slice, by nano-ESI MS. ApoA-I
fragments from untreated HDL were mostly localized in
slices 14-15 (Figure 4; panel A). These slices contained
peptides accounting for about 75% of ApoA-I aminoacid
sequence. Slice 5, corresponding to a protein band migrated
with apparent molecular mass of 73 kDa, also contained some
ApoA-I fragments, while all over the rest of the gel track
ApoA-I was barely detected. After HDL oxidation (Figure
4; panel B), ApoA-I fragments were markedly detected in
gel slices corresponding to molecular mass higher than
expected. Increased content of ApoA-I fragments in slices
1 to 7 and 9 to 10 was observed, and a smear of ApoA-I
fragments all over the track from slices 1 to 15 was detected.
In particular, ApoA-I fragments containing the sulfone forms
of Met-112 and Met-148 were detected in slice 5 (data not
shown). The same ApoA-I fragmentation pattern was de-
tected when HSA was used during HDL oxidation. Con-
versely, when Hpt was used during HDL oxidation (Figure
4; panel C), high molecular mass ApoA-I-containing proteins
did not form, as indicated by the distribution pattern of
ApoA-I fragments, which mostly matched that of untreated
HDL (see panel A). It is worth noting that sulfones from
Met-112 or Met-148 were not found. Since these residues
are very close or within, respectively, the ApoA-I sequence
interacting with Hpt (27), we argue that Hpt effectively
protected its binding site on HDL.
In addition to studying the Hpt protective effect on the
structure of ApoA-I, we wondered whether such an effect
was extended to minor HDL apolipoproteins. Consistently
with previous data (39), ApoD amino acid sequences were
mostly detected in slices 8 to 13 from the gel track loaded
with untreated HDL, while ApoC-II was found only in slices
18 and 19 (Figure 5; panel A). After processing of oxidized
HDL, ApoC-II fragments were found migrated similarly to
those in the pattern of untreated HDL, while ApoD peptide
fragments were detected in two track regions, one corre-
sponding to slice 1 and the other to slices 10 to 13 (Figure
5; panel B). The feature that ApoD and ApoC-II structures
are differently modified by oxidation suggests that not all
the HDL apolipoproteins are equally exposed to oxidative
stress, and only some of them react with other proteins to
form heavy complexes on the HDL surface. When Hpt was
present during the HDL oxidation, the formation of high
molecular mass complexes was prevented (Figure 5; panel
C), as already observed for ApoA-I (see Figure 4). In this
case, the ApoD pattern in panel C was similar to that in panel
A, and that of ApoC-II resulted unaffected. Details on the
number or length of the peptides detected are reported in
Tables 1 and 2. These data suggest that Hpt specifically
protects some HDL apolipoproteins from oxidative damage.
FIGURE 4: MS analysis of ApoA-I, oxidized in the presence or
absence of Hpt, after electrophoresis. Tracks 3, 4, and 5 of the gel
reported in Figure 2 were used. Panel A shows the migration of
native HDL. Panels B and C show the migration of HDL oxidized
in Hpt absence or presence, respectively. Each track was sliced
into 19 fragments, destained, and digested by trypsin. The ar-
rowheads indicate the slice numbers 5, 10, 14, and 18. The digestion
mixture obtained from each slice was processed for nano-ESI
analysis. The total intensity of peaks from Apo A-I fragments is
reported as a vertical bar in correspondence of each slice, and
expressed as arbitrary units from peak integration. The bars indicate
how ApoA-I (GI:82571472, precursor, 267 amino acids) is dis-
tributed all over the gel pattern. A given bar, when compared with
other bars, roughly expresses the relative amount of ApoA-I in the
pattern, because different ionization efficiency of each tryptic
peptide, different detection sensitivity at m/z, and simultaneous
acquisition of MS and MS/MS are all averaged by considering the
total mixture of ApoA-I fragments.
FIGURE 5: Electrophoretic analysis of oxidized ApoD or ApoC-II.
Tracks 3, 4, and 5 of the gel reported in Figure 2 were used. Panel
A shows the migration of native HDL. Panels B and C show the
migration of HDL oxidized in Hpt absence or presence, respectively.
Each track was sliced into 19 fragments, destained, and digested
by trypsin. The arrowheads indicate the slice numbers 5, 10, 14,
and 18. The digestion mixture obtained from each slice was
processed by nano-ESI analysis for detecting ApoD (black hori-
zontal bars) or ApoC-II (gray horizontal bars).
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Other proteins, like Hb which was added to HDL for radical
production, form high molecular mass complexes as much
as ApoA-I during oxidative stress, but they conversely were
not protected by Hpt (data not shown).
Oxidation of ApoA-I in HDL from Mice with Different Hpt
LeVels. Inflammation in mice was induced by carrageenan.
At different time lengths following the antigen administration
(0, 6, 24, 48, 72, 96, and 144 h), the animals were sacrificed
and their blood was collected. Plasma aliquots were used
for titration of ApoA-I and Hpt by ELISA, and for prepara-
tion of HDL. This lipoprotein fraction and other plasma
aliquots were processed for nano-ESI-nanospray MS/MS
analysis. ApoA-I levels in plasma, as detected by antibodies,
did not significantly change until 96 h following carrageenan
administration but were found decreased at 96 and 144 h,
while Hpt levels increased in the time range from 6 to 48
but dropped down to normal values later on (Figure 6). In
particular, the molar ratios of Hpt with ApoA-I were 0.68
( 0.10, 0.75 ( 0.06, 2.02 ( 0.17, 4.00 ( 0.32, 1.5 ( 0.30,
1.6 ( 0.10, and 1.60 ( 0.21 after 0, 6, 24, 48, 72, 96, and
144 h respectively. A fragment of plasma albumin (439-
452: APQVSTPTLVEAAR; from GI:5915682, precursor),
containing amino acids which were not affected by oxidation
and therefore representing the total protein amount (i.e.,
oxidized plus native forms), were detected by MS analysis
as signals with intensity decreased during inflammation, as
shown in Figure 7 (panel A). Albumin was also used as
marker of circulating proteins which are exposed to oxidative
stress, as its fragment 199-212 (ESCLTPKLDGVKEK) was
found harboring hydroxylated Pro-204 from 6-24 to 144 h
(Figure 7; panel B). Hydroxylation of Pro was assessed by
the finding of at least five peptide ions overlapping the
fragment amino acid sequence and displaying 16 Da higher
mass, corresponding to conversion of one proline residue
into 4-hydroxyproline, 5-hydroxyproline, or glutamic semi-
aldheyde. The plasma concentration of ApoA-I was too low
to be detected by MS. Therefore HDL, precipitated from
plasma by DS and then dissolved in small volume, was used
for MS analysis of ApoA-I. The fragment 142-154 (VA-
PLGAELQESAR; from GI:6753096, precursor), which was
never found oxidized, was used as marker of the ApoA-I
amount. The MS signal for this fragment was found
decreased in samples from blood collected during inflam-
mation (Figure 7; panel A). It is worth noting that the
decrease in the ApoA-I levels, as observed by MS analysis,
seems similar to that found by ELISA (Figure 7 panel A
versus Figure 6). Also for ApoA-I, as in the analysis of
albumin oxidation, hydroxylated Pro was chosen as marker
of damage by hydroxyl radical attack. The fragment 237-
247 (HSLMPMLETLK) was detected with hydroxylated Pro-
241 in apolipoprotein samples prepared from blood collected
72 to144 h after carrageenan administration (Figure 7; panel
B). In particular five peptide cations (three Y-type and two
B-type, i.e., starting at Asp-234 or ending at Glu-244
respectively), having different length but all overlapping part
of the fragment sequence, were detected. This result indicates
that ApoA-I was hydroxylated only late (i.e., after 72 h)
during inflammation, when the Hpt level dropped down, and
Table 1: Tryptic Fragments of ApoD in Gel Slicesa
slice coverage (%) peptides
A-9 9 152-164
A-10 21 76-92, 152-164, 165-175
A-11 17 52-60, 152-164, 165-175
A-12 25 46-51, 52-60, 76-82, 152-164,
165-175
A-13 33 8-21, 26-31, 32-40, 56-62, 132-144,
145-155
B-1 6 165-176
B-10 5 152-164
B-11 5 52-60
B-12 17 52-60, 152-164, 165-175
B-13 25 46-51, 52-60, 76-82, 152-164,
165-175
C-9 18 152-164, 165-185
C-10 21 52-60, 76-82, 152-164, 165-175
C-11 25 46-51, 52-60, 76-82, 152-164,
165-175
C-12 19 52-60, 76-82, 152-164, 165-175
C-13 24% 46-51, 52-60, 76-82, 152-164,
165-175
a Proteins from native (A) or oxidized HDL were fractionated by
electrophoresis on polyacrylamide gels. HDL oxidation was performed
in the absence (B) or presence (C) of Hpt. Each gel was cut into 19
slices, which were processed for ESI analysis as described in
Experimental Procedures. Only slices containing ApoD peptides are
shown. The protein sequence coverage was calculated from the sequence
length of the detected peptides. Each peptide sequence is expressed as
amino acid positions in the primary structure of ApoD (GI:13938509;
protein precursor; 189 residues).
Table 2: Tryptic Fragments of ApoC-II in Gel Slicesa
slice coverage (%) peptides
A-18 38 1-19, 20-30
A-19 87 1-19, 20-30, 31-39, 40-48, 56-76
B-19 35 1-19, 31-39
C-18 87 1-19, 20-30, 31-39, 40-48, 56-76
C-19 23 31-39, 40-48
a Proteins from native (A) or oxidized HDL were fractionated by
electrophoresis on polyacrylamide gels. HDL oxidation was performed
in the absence (B) or presence (C) of Hpt. Each gel was cut into 19
slices, which were processed for ESI analysis as under Experimental
Procedures. Only slices containing ApoC-II peptides are shown. The
protein sequence coverage was calculated from the sequence length of
the detected peptides. Each peptide sequence is expressed as amino
acid positions in the primary structure of ApoC-II (GI:14277770, 79
residues).
FIGURE 6: Titration of ApoA-I and Hpt in plasma from mice treated
with carrageenan. Mice were injected with 50 íL of 1% carrag-
eenan. After 6, 24, 48, 72, 96, and 144 h groups of three animals
were sacrificed. One group was not treated and served as control
(time 0). Blood was collected, and plasma from each animal was
prepared. Samples (N ) 3) were analyzed by ELISA for measuring
the concentration of ApoA-I and Hpt. Rabbit anti-ApoA-I or anti-
Hpt IgG was used to form immunocomplexes, which were
incubated with GAR-HRP and, then, OPD and H2O2 for color
development. Absorbance at 492 nm was measured, and the level
of ApoA-I (open circles) or Hpt (filled circles) was determined
using mouse Apo A-I and Hpt for calibration. The data are
expressed as means ( SEM. In this figure a typical experiment is
shown. Comparable data (no significant difference between values
at each time point) from other two separate experiments were
obtained.
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the Hpt/ApoA-I ratio decreased to 1.5. Conversely, ApoA-I
was not oxidized on its Pro-241 when Hpt circulated at higher
levels (Hpt/ApoA-I ratio ) 2-4), even though albumin was
attacked by hydroxyl radicals.
Radical Attack to Free or Hpt-Bound ApoA-I: Effect on
Stimulation of LCAT. Oxidative damage of ApoA-I structure
might affect the protein property of stimulating the enzyme
LCAT for production of cholesteryl esters. The LCAT
activity is commonly measured by using ApoA-I embedded
in micelles containing, as enzyme substrates, phospholipids
and 3H-labeled cholesterol. These proteoliposomes were
incubated at first with the oxidizing mixture of Hb, ascorbate,
and H2O2 (0.5, 100, and 100 íM in TBS, respectively), and
then with LCAT. The second incubation was done 1 h after
the end of the first one, when radicals were no more produced
(see Experimental Procedures). Not oxidized samples (i.e.,
proteoliposomes with only TBS in the first incubation) were
used as positive controls to confirm the ApoA-I effect on
LCAT. The enzyme activity was found significantly impaired
by oxidized proteoliposomes (4.71 ( 0.31 versus 9.49 (
0.16 U in controls, P < 0.003). Absence of either ascorbate
or Hb during the proteoliposome treatment did not alter the
enzyme activity (8.95 ( 0.42 or 10.12 ( 0.45 U respec-
tively).
LCAT assays with proteoliposomes oxidized in the pres-
ence of Hpt were performed in order to evaluate whether
this protein can protect not only the structure but also the
function of ApoA-I. The effect of 0.5 íM Hpt, during
oxidative treatment of the proteoliposome with different
amounts of Hb, was clearly protective for ApoA-I function
(Figure 8; panel A). In a further experiment, the radical
source was kept constant (0.5 íM Hb in the oxidizing
mixture), and the effect of higher Hpt concentrations in the
LCAT assay was studied (Figure 8; panel B). The data
obtained indicate that the proteoliposomes oxidized in the
presence of 0.5 íM Hpt (Hpt/ApoA-I ratio ) 2.5) stimulated
the enzyme as those not oxidized. Conversely, the proteo-
liposomes oxidized in the presence of increasing amounts
of Hpt (Hpt/ApoA-I ratio from 5 to 50) severely impaired
the cholesterol esterification. Finally, experiments with
proteoliposomes oxidized in the presence of the peptide P2a
were carried out. This peptide contains (part of) the ApoA-I
sequence interacting with Hpt, and can therefore displace
Hpt from HDL (27). Use of such a peptide, during proteo-
FIGURE 7: MS analysis of ApoA-I and albumin from mice treated
with carrageenan. Mice were injected with 50 íL of 1% carrag-
eenan. After 6, 24, 48, 72, 96, and 144 h groups of three animals
were sacrificed. One group was not treated and served as control
(time 0). Blood was collected, and plasma from each group was
pooled. Samples from each pool were processed as such for albumin
analysis, or treated with DS for isolating HDL. Untreated samples
and isolated HDL were digested by trypsin, and the resulting
polypeptide fragments were analyzed by nano-ESI MS for detection
of albumin and ApoA-I amino acid sequences respectively. In panel
A, the relative amounts of fragment 439-452 of albumin (open
squares) and fragment 142-154 of Apo A-I (open circles), which
were never found oxidized and therefore originated from both
oxidized and native protein, are shown. In panel B, signal intensities
for fragment 199-212 of albumin (filled squares) and fragment
237-247 of ApoA-I (filled circles), which harbor hydroxylated
proline residues, are shown. GI:5915682 and GI:6753096 were used
for identification of albumin and ApoA-I peptides respectively.
Hydroxyproline was identified by at least three Y-type and two
B-type ions originated from these fragments (¢m/z ) +16). The
intensities of the spectrometer signals are expressed in arbitrary
units. Samples from each time length of treatment were processed
in duplicate, and averages and deviations were calculated. Averages
and deviations (ApoA-I, positive deviations; albumin, negative
deviations) from one experiment are shown. Three separate
experiments were carried out. Interassay coefficients of variation
for signal intensity, at each time length, were never found higher
than 8%.
FIGURE 8: LCAT assay with oxidized proteoliposomes. The LCAT
activity was assayed by incubating a pool of dextran sulfate-treated
plasma with a reaction mixture, containing a labeled proteoliposome
(ApoA-I:lecithin:3H-cholesterol, 1.5:200:18 molar ratio) as substrate.
Before incubation, the proteoliposome was kept in TBS (open circle,
in all the panels), or TBS supplemented with oxidizing mixtures.
Panel A shows the activity measured by using proteoliposomes
oxidized with different Hb concentrations in the presence (filled
circles) or absence (open squares) of 0.5 íM Hpt. Panel B shows
the activity measured by using proteoliposomes oxidized with 0.5
íM Hb in the presence of different concentrations of Hpt (filled
circles). Panel C shows the activity measured by using proteoli-
posomes oxidized with 0.5 íM Hb and 0.5 íM Hpt, in the presence
of different concentrations of the peptide P2a (filled circles); a
control assay was performed with proteoliposomes oxidized in the
absence of Hpt (open square). The LCAT activity was expressed
as units (1 U ) one nanomole of cholesterol incorporated per hour
per milliliter of plasma). The samples were analyzed in triplicate:
the data are expressed as means ( SEM.
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liposome oxidation in the presence of 0.5 íM Hpt, was
expected to impair the interaction of Hpt with ApoA-I, which
should thus be exposed to the hydroxyl attack. Increased
amounts of peptide were actually found associated with
decreased LCAT activity (Figure 8; panel C).
These results, taken together, indicate that Hpt might
effectively prevent Hb-triggered oxidative damage of ApoA-I
function when the Hpt/ApoA-I molar ratio is comparable
with that present in physiological conditions (29). Further-
more the data suggest that Hpt, at high concentration or when
bound by P2a, is no more able to save the ApoA-I role in
the LCAT stimulation.
DISCUSSION
During inflammation, the plasma level of Hpt increases
(16) as well as the release of free Hb from erythrocytes (40),
and the production of reactive oxygen species from the
endothelium (15). ApoA-I is known to be a target of
oxidative stress (8-12), but poor information is available
on the effect of the attack of hydroxyl radicals on its structure
and function (8, 41, 42). This attack may be a major cause
of ApoA-I modification, not only because HDL are exposed
to circulating free Hb, but also owing to the binding of
ApoA-I to Hpt and therefore complexes Hpt-Hb, which are
potential sources of hydroxyl radicals. In this work, we set
up a system of oxidative stress based on levels of Hb, H2O2
and ascorbate in the range from physiological to inflamma-
tory conditions, and demonstrated that the hydroxyl attack
modified the ApoA-I structure. ApoA-I molecules might be
converted into homodimers or heterodimers with other HDL
apolipoproteins. Hydroxyl radicals can actually produce
tyrosyl radicals on Tyr residues of ApoA-I, thus cross-linking
two ApoA-I molecules or ApoA-I with ApoA-II (8). These
adducts were previously found in mouse HDL following
oxidation by hydroxyl radicals (43). Antibodies are a
powerful tool to identify or isolate cross-linked apolipopro-
teins. We used anti-ApoA-I antibodies to detect, after SDS-
PAGE and Western blotting, ApoA-I-containing epitopes
among the products originated from HDL by oxidative stress.
Antigens with electrophoretic mobility lower than ApoA-I,
namely, molecules containing ApoA-I or part of it cross-
linked with other apolipoproteins or peptide fragments,
displayed higher immunoreactivity, which was likely de-
pendent on epitopes exposed by oxidation (44). Poor
immunoreactivity of ApoA-I, following oxidation by Fenton
chemistry, was already described (42). It cannot be excluded
that peptide fragments originated from ApoA-I, in the
oxidation system we used, but were not detected by the
antibodies, likely because they were very short or presenting
epitopes altered by oxidation. It is worth noting that the
production of high molecular mass ApoA-I-containing
antigens was greatly limited by Hpt, whereas it was not
impaired by albumin. This result clearly indicates that
albumin, known as the most abundant plasma protein and
an effective radical scavenger, does not prevent ApoA-I
oxidation in the assay conditions, and strongly suggests that
the antioxidant role of Hpt is specifically protective for
ApoA-I. This is a major result from our work, and enlightens
a new property of Hpt.
Recently, LDL and HDL proteins were intensively studied
by the rapidly expanding use of MS, and some information
on lipoproteomics associated with different diseases is now
available (39, 45). Even though the protein composition of
HDL from different conditions was examined with some
detail by MS analysis, this technology has never been used,
to the best of our knowledge, for studying the effect of
oxidation on HDL and, in particular, on ApoA-I. Nano-ESI,
given its high resolving power, due to chromatographic
separation of tryptic peptides before MS, is a suitable
technique for analyzing complex protein mixtures like those
of HDL. In this lipoprotein environment, the ApoA-I
oxidation was studied. MS analysis allowed us to ascertain
that the protective effect of Hpt on ApoA-I is mostly
displayed by preventing the formation of covalent adducts
of this apolipoprotein with other proteins. As a consequence
of the radical attack, also ApoD or ApoD fragments cross-
linked or reacted with other HDL proteins, and formed high
molecular mass adducts. It is worth noting that Hpt prevented
the formation of such adducts. Thus the importance of Hpt
might be extended over the antioxidant defense of ApoA-I.
In particular, we present here the hypothesis that HDL-bound
Hpt might save structure and function also of apolipoproteins
other than (and, possibly, neighboring to) ApoA-I. Differently
from ApoA-I and ApoD, ApoC-II did not seem to form
adducts with other apolipoproteins. This means that reactive
fragments of ApoC-II, if produced in our oxidation system,
were under the detection threshold in MS analysis. It cannot
be excluded that ApoC-II is a poor target for hydroxyl
radicals, or is shielded by some other apolipoprotein on the
HDL surface.
The Hpt protective effect on the ApoA-I structure during
in vitro oxidation was supported by the results obtained from
the experiment with carrageenan-treated mice. High Hpt
levels were actually found associated with no detectable
hydroxyproline in the structure of ApoA-I from HDL
collected in inflammatory conditions. Conversely, hydrox-
yproline in ApoA-I was formed only when the Hpt level
dropped down in inflamed mice. This finding suggests that
Hpt, when circulating at a level sufficiently high for binding
HDL, prevents hydroxylation of ApoA-I. Detection of
hydroxyproline-containing fragments was used to study
ApoA-I oxidative damage because hydroxylation of proline
residues can be considered a footprint of hydroxyl radical
attack to polypeptide chains (15, 46), which are not cleaved
by such an attack (47, 48) and result therefore labeled for
further analysis. The analysis was performed by MS, which
is to date the best tool not only for identifying hydroxylation
targets but also for assigning the attached hydroxyl to specific
residues in a given amino acid sequence. Hydroxylated
aliphatic amino acids are also suitable footprints for studying
metal ion-catalyzed Fenton chemistry with proteins (49), but
most of these amino acid residues of ApoA-I might be
hydroxylation targets poorer than proline. In fact, they are
not exposed to water solution as embedded in the HDL lipid
fraction, which is more susceptible than apolipoproteins to
oxidation (8).
Sulfoxides of Met-86 and Met-112 were previously found
not decreasing the ApoA-I activity in LCAT stimulation in
vitro (41). It cannot be excluded that sulfone but not sulfoxide
forms of the oxidized Met residues change the function of
ApoA-I. We found that sulfone forms of Met-112 and Met-
148 were produced by our oxidation system in the presence
of 6 íM Hb, and that the enzyme activity resulted heavily
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impaired also at lower Hb concentration. It should be noted
that Met-148 lies just in the ApoA-I domain interacting with
the enzyme (28), and its conversion into the sulfone form
might be responsible for decreased cholesterol esterification
in the in vitro assay. However, oxidation of residues other
than methionine might be involved in loss of ApoA-I
function. The LCAT assay confirmed the hypothesis that Hpt,
as interacting with ApoA-I, prevents this apolipoprotein from
losing its function of stimulating the enzyme. This interaction
is based on chemical equilibrium between free and Hpt-
bound ApoA-I, and such equilibrium is regulated by the Hpt
concentration, according to the mass action law. It is therefore
conceivable that the higher the Hpt concentration, the lower
the amount of free ApoA-I, and the lower the stimulation
on LCAT. As a matter of fact, we found full stimulation of
the enzyme activity with 0.5 í» Hpt. This Hpt concentration
was about 2-fold that of ApoA-I in the assay, in stoichio-
metric ratio which is comparable with that present in
physiological conditions (16, 29). The ApoA-I stimulation
decreased as much as higher Hpt concentration, resembling
the raising of Hpt levels during the acute phase of inflam-
mation (16, 29), was used in the LCAT assay (see Figure 8,
panel B). This means that, in these conditions, the amount
of free ApoA-I decreased, owing to competition of Hpt with
LCAT for the same binding site on the apolipoprotein
structure. Inhibition of LCAT in vitro by increasing levels
of Hpt was already reported (27, 50), and the stoichiometric
ratio of Hpt with ApoA-I was previously found negatively
correlated with the enzyme activity in vivo (29). The enzyme
assay was carried out also to confirm the hypothesis that
Hpt effectively prevents the oxidative damage of the ApoA-I
function in stimulating LCAT. In fact, the protective Hpt
property against hydroxyl radicals was lost when the
synthetic peptide P2a, sharing amino acid sequence with the
ApoA-I binding domain for Hpt (27), was used during the
oxidative stress. The results suggest that such a peptide
competed with ApoA-I for the Hpt binding, therefore keeping
Hpt separated from ApoA-I, and leaving the apolipoprotein
exposed to hydroxyl radicals. We want to point out that the
here presented results were obtained by using Hpt prepara-
tions which were mixtures of the three protein phenotypes.
Hpt should generally behave as scavenger of reactive oxygen
species, and the role of Hpt polymorphism in protecting
ascorbate (51) or LDL (52) against hydroxyl radicals was
previously reported. The Hpt isoforms, as having different
molecular mass or conformation, are expected to differently
protect also ApoA-I from oxidative damage. In fact, it seems
conceivable that the ApoA-I structure be protected from
hydroxyl attack by Hpt steric hindrance. Therefore, the
efficiency of different isoforms in masking HDL oxidation
targets is expected to change, as depending on how large is
the shield resulting from Hpt isoform structure. In this frame,
a link between Hpt polymorphism and antioxidant defense
of ApoA-I function can also be hypothesized.
It remains to be discussed why Hpt would limit the reverse
cholesterol transport during the acute phase of the inflam-
mation, just when oxidative stress reaches its highest level,
and the resulting oxidized LDL promotes cholesterol ac-
cumulation in the cells of the vascular wall. A possible
interpretation of our data is that a regulatory mechanism for
the ApoA-I function might exist, based on a balance of
advantages and disadvantages. It is worth noting that ApoA-
I, in addition to the property of stimulating LCAT, displays
other important activities (51-53) which might be saved by
Hpt during oxidative stress as well. In this frame, it is
conceivable that Hpt might compete with the heme protein
myeloperoxidase for binding ApoA-I, thus limiting the
enzyme-catalyzed oxidation which impairs the HDL function
as observed in subjects with cardiovascular disease (12).
Therefore Hpt might act as a defense for ApoA-I against
oxidation and loss of function both in physiological condi-
tions, when significant though low levels of radicals are
continuously produced (15), and during the acute phase of
inflammation, when severe oxidative stress occurs. In the
former case, ApoA-I protection by Hpt would not impair
the stimulation of LCAT, the amount of Hpt-free ApoA-I
being sufficient for such an activity: this protection might
be addressed to prolong the HDL life. In the latter case, the
enhanced levels of Hpt would bind so many ApoA-I
molecules that LCAT activity would suffer by lack of
stimulation. This condition should not be prolonged, other-
wise the reverse cholesterol transport would be severely
limited. We suggest that, so far as the acute phase and the
associated enhanced Hpt levels last a short time, ApoA-I
protection represents an advantage because this apolipopro-
tein would be ready to work as soon as inflammation goes
out and Hpt returns to normal levels.
Although further experiments, including epidemiologic
studies and clinical trials, are required to validate our model
on the importance of the ApoA-I binding of Hpt, our data
strongly suggest that therapeutic interventions for treatment
of cardiovascular disease might target Hpt with drugs
competing for the ApoA-I binding only if combinatorial
antioxidant administration is provided.
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